The medical device industry is a $570-620B global market growing 5-7% annually, with research demand split across three buyer types: vendors sizing opportunities, investors evaluating theses, and operators making go-to-market bets. The research ecosystem that serves them runs from $3K syndicated reports up to $250K+ analyst subscriptions -- but free FDA, CMS, SEC, and PubMed data answers the majority of operating questions before any paid source is needed.
Below: industry size and growth, the top market research firms covering medtech, what each tier costs and when it's worth it, the public data sources every team should use first, and the three-layer approach that produces research executives actually trust.
"Market research medical device industry" is one of the highest-intent searches medtech operators run. The people typing it fall into three buckets: founders and product leaders sizing a new opportunity, corporate development teams evaluating a category before an acquisition or partnership, and marketing leaders building a positioning case for an executive review. This guide is written for all three, grounded in what we see across client engagements rather than any single analyst report.
We cover the current size and growth of the medical device industry, the research firms that actually serve it, what each source tier costs, the free public data that most teams underuse, and the three-layer approach we recommend for combining sources into research that survives executive scrutiny.
The Medical Device Industry at a Glance
Analyst estimates for the 2026 global medical device industry cluster between $570 billion and $620 billion, with most published forecasts projecting a CAGR of 5-7% through 2030. The United States represents 40-43% of global spend, Europe roughly 25%, and Asia-Pacific is the fastest-growing region by percentage, led by China, India, and Southeast Asia.
The largest segments by revenue are cardiovascular devices, orthopedic and spine, in vitro diagnostics, surgical robotics and minimally invasive surgery, and imaging. Faster-growing sub-segments include continuous glucose monitoring, surgical robotics, structural heart, neuromodulation, and AI-enabled diagnostic software.
Differences between published estimates almost always come down to category boundary. Narrow definitions exclude IVD, capital equipment, and digital health and put the global figure closer to $470-500B. Broad definitions include all of those plus dental and ophthalmic and put it closer to $620B+. When you compare two market sizing reports, always check the category map before you compare the headline number.
The Three Tiers of Medical Device Industry Research
The research ecosystem serving the medtech industry resolves into three tiers. Each has a different cost profile, refresh cadence, and best use case.
Tier 1: Premium analyst subscriptions
GlobalData Medical, IQVIA MedTech, Clarivate, Frost and Sullivan, and Decision Resources Group sit at the top of the market. Annual subscriptions run $40,000 to $250,000+ depending on category coverage. The product is a continuously updated database of company profiles, pipeline trackers, deal data, and analyst commentary, plus access to inquiry calls.
Worth it when: you operate in a single category continuously, need defensible numbers for board reviews, or run an active corporate development function.
Skip when: you have a single project or category and don't need ongoing access. A focused syndicated report and 10 physician interviews will get you further per dollar.
Tier 2: Syndicated published reports
Grand View Research, MarketsandMarkets, Mordor Intelligence, Fortune Business Insights, and Research and Markets dominate this tier. Single-user licenses typically cost $3,000 to $7,000 per report. Coverage is broad -- almost every device sub-segment has a published report -- but report quality varies. Some reports are well-sourced primary work; others are heavily templated.
Worth it when: you need a defensible top-down market size for a single category, a competitor map, or a trend overview, and you don't need ongoing updates.
Watchout: always cross-check the headline market size against a bottom-up procedure or installed-base build. We cover that triangulation in our medical device market research methods post and our AI tools for medical device market sizing guide.
Tier 3: Procedure-volume and claims data
iData Research, SmartTRAK, Definitive Healthcare, and Komodo Health provide procedure-level data: how many of a given procedure are performed where, by which physicians, in which settings, with what reimbursement. Subscriptions typically run $25,000 to $150,000 per year. For surgical and procedure-driven medtech categories, this data is the single most operationally useful research investment a team can make -- it powers TAM, sales targeting, and field force planning all from one source.
Worth it when: your device ties to a specific CPT code or procedure type, and you need account-level or physician-level targeting in addition to market sizing.
The number to compare across vendors is not market size.
Vendors all triangulate to similar headline numbers. The real differentiation is data freshness, the granularity of the segment cuts, and whether the data ties back to identifiable accounts and physicians. For most medtech operators, claims-data tier products beat syndicated reports for go-to-market planning -- the cost is higher, but it answers the questions you actually have to act on.
The Free Public Data Most Teams Underuse
Before any paid research investment, every medtech team should be running a structured pull from five public data sources. These answer 70% of typical market research questions for the medical device industry at zero cost.
FDA databases. The 510(k), PMA, registration, MAUDE, and recall databases together give a complete view of competitive clearances, adverse-event signals, market entries, and product histories. The Establishment Registration database identifies every U.S. and foreign manufacturer for a given device class. We use FDA data on every project. See our 510(k) marketing strategy guide for how to translate clearance data into competitive intelligence.
CMS data. Procedure volumes by HCPCS and CPT code, reimbursement rates by site of service, the Hospital Outpatient Prospective Payment System data, and the Open Payments database covering industry-physician financial relationships. CMS data is the foundation of any bottom-up sizing work for a U.S. medtech category.
SEC EDGAR. Every public medtech competitor publishes detailed segment financials, geographic splits, R&D pipeline disclosures, and risk factors quarterly. For competitive benchmarking, EDGAR is more useful than any paid analyst report because it is the source the analysts themselves are reading.
PubMed and ClinicalTrials.gov. Together they reveal the clinical evidence and trial pipeline shaping each category. Trial registrations are a leading indicator of product launches 18-36 months out. Our AI competitive intelligence for medical devices piece covers how to automate monitoring of these sources.
BLS and AAMC workforce data. The supply side -- how many specialists are practicing, where, growth rates -- often determines whether a category can grow at the rate analyst reports forecast. A device that depends on a flat or shrinking specialist pool has a ceiling no syndicated report headline number captures.
Need market research that survives an executive review?
We design and run market research programs for medtech operators -- combining FDA, CMS, syndicated, and primary sources into a defensible go-to-market case. 30-minute call, no pitch.
Book a Strategy Call →The Three-Layer Approach We Recommend
The single biggest mistake we see in medtech market research is starting with the most expensive method. Teams commission $80,000 advisory boards before they have a hypothesis to test, or buy three syndicated reports without a sizing model to validate them against. The fix is sequencing.
Layer 1 -- Public data foundation (1-2 weeks). Pull a structured FDA, CMS, SEC, PubMed, and ClinicalTrials.gov dataset for the category. Build a baseline competitive map, a bottom-up procedure-driven TAM, and a trial-pipeline view. This produces the questions worth asking in subsequent layers.
Layer 2 -- Syndicated and claims data (2-4 weeks). Buy one or two focused syndicated reports to validate market sizing and surface trends. If your category is procedure-driven and the budget allows, layer in a claims or procedure-volume data subscription. This is where most teams stop, but it shouldn't be the last step.
Layer 3 -- Primary research (4-8 weeks). Run 8 to 15 physician interviews, an advisory board, or a quantitative survey of 100+ targeted clinicians to test the specific hypotheses Layers 1 and 2 produced. Recruiting through KOL relationships outperforms cold panel recruiting on quality. Our third-party market research for medical devices guide covers vendor selection for this layer.
The output of this sequence is a research deliverable that survives executive scrutiny because every conclusion can be defended from at least two sources. We have never seen a market sizing or positioning case fall apart in a board review when this sequence was followed.
Trends Reshaping Medical Device Industry Research
Three trends are changing how medtech market research gets done in 2026.
AI-assisted synthesis is real. Tools that mine FDA, PubMed, ClinicalTrials.gov, and competitor disclosures with LLM-driven extraction are collapsing the time required for Layer 1 from weeks to days. Our AI medical device marketing guide covers the broader category. The implication: teams that still do public-data pulls manually are at a meaningful speed and cost disadvantage.
Claims-data subscriptions are eating syndicated reports. For surgical and procedure-driven categories, the operational utility of physician-level claims data has made traditional syndicated reports a complement rather than a primary source. Budgets are shifting accordingly.
Buyer panels are getting harder. Physician participation in research panels has declined as inbox volume has risen. Teams that recruit through KOL relationships, professional society partnerships, and physician compensation platforms outperform teams that rely on traditional panels. We cover the recruiting side in our medical device market research methods piece.
The Bottom Line
The medical device industry is a $570-620B market with a research ecosystem that ranges from free public databases to $250K analyst subscriptions. The teams that get the most leverage from research are not the ones who spend the most -- they are the ones who sequence sources correctly, exhaust free public data before any paid investment, triangulate market size estimates, and finish with targeted primary research that tests sharp hypotheses rather than broad questions.
If you want a second opinion on a specific market sizing model, a research vendor selection, or how to structure a research program for a new category launch -- book a 30-minute call. We will tell you exactly what we would do in your shoes, even if we never work together.